Skip to main content
Norris Cotton Cancer Center
In This Section

Recently Opened Clinical Trials for June 2014

Thomas Davis
Associate Professor
Cancer Control

Phase II randomized trial of transoral surgical resection followed by low-dose or standard-dose IMRT in resectable p16+ locally advanced oropharynx cancer

Marc Ernstoff
Immunology and Cancer Immunotherapy

Cancer Immunotherapy Trials Network (CITN)
A Phase 1 study of the clinical and immunologic effects of ALT-803, a novel recombinant IL-15 complex in patients with advanced melanoma

Lesley Jarvis
Assistant Professor
Cancer Imaging and Radiobiology

Department Funded
Cherenkov imaging in radiation therapy

Peter Kaufman
Associate Professor
Molecular Therapeutics

Hoffman LaRoche
A randomized, multicenter, open-label, Phase III trial comparing trastuzumab plus pertuzumab plus a taxane following anthracyclines versus trastuzumab emtansine plus pertuzumab following anthracyclines as adjuvant therapy in patients with operable HER2-positive primary breast cancer

Lionel Lewis
Molecular Therapeutics

Molecular Therapeutics
A dose-finding Phase Ib multicenter study of imatinib in combination with the oral Phosphatidyl-Inositol 3-Kinase (PI3K) inhibitor BYL719 in patients with Gastrointestinal Stromal Tumor (GIST) who failed prior therapy with imatinib and sunitinib